India, May 12 -- Roche Holding AG (RHHBY), Monday announced plans to invest over $700 million in a new state-of-the-art drug manufacturing facility in Holly Springs, North Carolina, creating more than 400 high-wage manufacturing and over 1,500 construction jobs in the region.
The new facility is expected to support Roche and Genentech's future portfolio of next-generation obesity medicines. Moreover, the investment could expand in the future based on business needs and the U.S. policy environment.
Currently, Roche's stock is trading at $38.53, up 0.68 percent on the OTC Markets.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....